nodes	percent_of_prediction	percent_of_DWPC	metapath
Topiramate—GRIA2—amyotrophic lateral sclerosis	0.41	1	CbGaD
Topiramate—SCN5A—Riluzole—amyotrophic lateral sclerosis	0.284	1	CbGbCtD
Topiramate—GRIK1—peripheral nervous system—amyotrophic lateral sclerosis	0.00408	0.0494	CbGeAlD
Topiramate—GRIA4—nerve—amyotrophic lateral sclerosis	0.00363	0.0439	CbGeAlD
Topiramate—GRIK1—nerve—amyotrophic lateral sclerosis	0.00318	0.0385	CbGeAlD
Topiramate—GRIA3—nerve—amyotrophic lateral sclerosis	0.00296	0.0358	CbGeAlD
Topiramate—GRIA4—hindbrain—amyotrophic lateral sclerosis	0.00272	0.0329	CbGeAlD
Topiramate—Hypoaesthesia oral—Riluzole—amyotrophic lateral sclerosis	0.00259	0.023	CcSEcCtD
Topiramate—GRIK5—hindbrain—amyotrophic lateral sclerosis	0.00251	0.0304	CbGeAlD
Topiramate—GRIK1—hindbrain—amyotrophic lateral sclerosis	0.00238	0.0288	CbGeAlD
Topiramate—Manic psychosis—Riluzole—amyotrophic lateral sclerosis	0.00171	0.0152	CcSEcCtD
Topiramate—Paranoid reaction—Riluzole—amyotrophic lateral sclerosis	0.00159	0.0141	CcSEcCtD
Topiramate—GRIA1—nerve—amyotrophic lateral sclerosis	0.00158	0.0191	CbGeAlD
Topiramate—Personality disorder—Riluzole—amyotrophic lateral sclerosis	0.00156	0.0139	CcSEcCtD
Topiramate—GRIA4—brainstem—amyotrophic lateral sclerosis	0.00156	0.0189	CbGeAlD
Topiramate—Paraesthesia oral—Riluzole—amyotrophic lateral sclerosis	0.00144	0.0128	CcSEcCtD
Topiramate—GRIK5—brainstem—amyotrophic lateral sclerosis	0.00144	0.0174	CbGeAlD
Topiramate—Endophthalmitis—Riluzole—amyotrophic lateral sclerosis	0.00142	0.0126	CcSEcCtD
Topiramate—GRIK1—brainstem—amyotrophic lateral sclerosis	0.00137	0.0165	CbGeAlD
Topiramate—White blood cell count decreased—Riluzole—amyotrophic lateral sclerosis	0.00136	0.0121	CcSEcCtD
Topiramate—Faecal incontinence—Riluzole—amyotrophic lateral sclerosis	0.00134	0.0119	CcSEcCtD
Topiramate—Lymphopenia—Riluzole—amyotrophic lateral sclerosis	0.00132	0.0117	CcSEcCtD
Topiramate—Renal pain—Riluzole—amyotrophic lateral sclerosis	0.00129	0.0114	CcSEcCtD
Topiramate—Urine abnormality—Riluzole—amyotrophic lateral sclerosis	0.00122	0.0108	CcSEcCtD
Topiramate—Hypothermia—Riluzole—amyotrophic lateral sclerosis	0.00121	0.0107	CcSEcCtD
Topiramate—Body temperature decreased—Riluzole—amyotrophic lateral sclerosis	0.00121	0.0107	CcSEcCtD
Topiramate—Suicide attempt—Riluzole—amyotrophic lateral sclerosis	0.00119	0.0106	CcSEcCtD
Topiramate—Gingival bleeding—Riluzole—amyotrophic lateral sclerosis	0.00119	0.0106	CcSEcCtD
Topiramate—Micturition urgency—Riluzole—amyotrophic lateral sclerosis	0.00119	0.0106	CcSEcCtD
Topiramate—GRIA1—hindbrain—amyotrophic lateral sclerosis	0.00118	0.0143	CbGeAlD
Topiramate—Completed suicide—Riluzole—amyotrophic lateral sclerosis	0.00115	0.0102	CcSEcCtD
Topiramate—Urine analysis abnormal—Riluzole—amyotrophic lateral sclerosis	0.00115	0.0102	CcSEcCtD
Topiramate—Generalised oedema—Riluzole—amyotrophic lateral sclerosis	0.00114	0.0101	CcSEcCtD
Topiramate—GRIK2—nerve—amyotrophic lateral sclerosis	0.00113	0.0137	CbGeAlD
Topiramate—Enlargement abdomen—Riluzole—amyotrophic lateral sclerosis	0.00112	0.00998	CcSEcCtD
Topiramate—Libido increased—Riluzole—amyotrophic lateral sclerosis	0.00111	0.00987	CcSEcCtD
Topiramate—GRIA4—medulla oblongata—amyotrophic lateral sclerosis	0.00109	0.0131	CbGeAlD
Topiramate—Embolism—Riluzole—amyotrophic lateral sclerosis	0.00105	0.00935	CcSEcCtD
Topiramate—Tooth disorder—Riluzole—amyotrophic lateral sclerosis	0.00104	0.00925	CcSEcCtD
Topiramate—GRIK4—nervous system—amyotrophic lateral sclerosis	0.00103	0.0125	CbGeAlD
Topiramate—Upset stomach—Riluzole—amyotrophic lateral sclerosis	0.00103	0.00916	CcSEcCtD
Topiramate—Calculus of kidney—Riluzole—amyotrophic lateral sclerosis	0.00103	0.00916	CcSEcCtD
Topiramate—GRIK3—medulla oblongata—amyotrophic lateral sclerosis	0.001	0.0121	CbGeAlD
Topiramate—GRIK5—medulla oblongata—amyotrophic lateral sclerosis	0.001	0.0121	CbGeAlD
Topiramate—Hypokinesia—Riluzole—amyotrophic lateral sclerosis	0.001	0.00889	CcSEcCtD
Topiramate—GRIK4—central nervous system—amyotrophic lateral sclerosis	0.000995	0.012	CbGeAlD
Topiramate—Paranoia—Riluzole—amyotrophic lateral sclerosis	0.000992	0.00881	CcSEcCtD
Topiramate—Seborrhoeic dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000992	0.00881	CcSEcCtD
Topiramate—GRIK4—cerebellum—amyotrophic lateral sclerosis	0.000972	0.0118	CbGeAlD
Topiramate—GRIA4—spinal cord—amyotrophic lateral sclerosis	0.000969	0.0117	CbGeAlD
Topiramate—Depersonalisation—Riluzole—amyotrophic lateral sclerosis	0.000964	0.00856	CcSEcCtD
Topiramate—Delusion—Riluzole—amyotrophic lateral sclerosis	0.000955	0.00848	CcSEcCtD
Topiramate—GRIK1—medulla oblongata—amyotrophic lateral sclerosis	0.000953	0.0115	CbGeAlD
Topiramate—Apathy—Riluzole—amyotrophic lateral sclerosis	0.000947	0.0084	CcSEcCtD
Topiramate—Metrorrhagia—Riluzole—amyotrophic lateral sclerosis	0.000947	0.0084	CcSEcCtD
Topiramate—GRIA2—hindbrain—amyotrophic lateral sclerosis	0.00094	0.0114	CbGeAlD
Topiramate—Laryngitis—Riluzole—amyotrophic lateral sclerosis	0.000938	0.00833	CcSEcCtD
Topiramate—Flat affect—Riluzole—amyotrophic lateral sclerosis	0.000938	0.00833	CcSEcCtD
Topiramate—Mania—Riluzole—amyotrophic lateral sclerosis	0.00093	0.00825	CcSEcCtD
Topiramate—Stupor—Riluzole—amyotrophic lateral sclerosis	0.000906	0.00804	CcSEcCtD
Topiramate—Glaucoma—Riluzole—amyotrophic lateral sclerosis	0.000898	0.00797	CcSEcCtD
Topiramate—GRIK3—spinal cord—amyotrophic lateral sclerosis	0.000894	0.0108	CbGeAlD
Topiramate—GRIK5—spinal cord—amyotrophic lateral sclerosis	0.000894	0.0108	CbGeAlD
Topiramate—GRIA3—medulla oblongata—amyotrophic lateral sclerosis	0.000886	0.0107	CbGeAlD
Topiramate—Amblyopia—Riluzole—amyotrophic lateral sclerosis	0.000876	0.00777	CcSEcCtD
Topiramate—SCN1A—hindbrain—amyotrophic lateral sclerosis	0.000858	0.0104	CbGeAlD
Topiramate—GRIK1—spinal cord—amyotrophic lateral sclerosis	0.00085	0.0103	CbGeAlD
Topiramate—GRIK2—hindbrain—amyotrophic lateral sclerosis	0.000849	0.0103	CbGeAlD
Topiramate—Nephrolithiasis—Riluzole—amyotrophic lateral sclerosis	0.000841	0.00747	CcSEcCtD
Topiramate—CA1—nerve—amyotrophic lateral sclerosis	0.00084	0.0102	CbGeAlD
Topiramate—Ageusia—Riluzole—amyotrophic lateral sclerosis	0.000835	0.00741	CcSEcCtD
Topiramate—Gamma-glutamyltransferase increased—Riluzole—amyotrophic lateral sclerosis	0.000822	0.0073	CcSEcCtD
Topiramate—GRIA4—nervous system—amyotrophic lateral sclerosis	0.000817	0.00988	CbGeAlD
Topiramate—Endocrine disorder—Riluzole—amyotrophic lateral sclerosis	0.000816	0.00724	CcSEcCtD
Topiramate—GRIA3—spinal cord—amyotrophic lateral sclerosis	0.00079	0.00956	CbGeAlD
Topiramate—GRIK4—brain—amyotrophic lateral sclerosis	0.00079	0.00955	CbGeAlD
Topiramate—Delirium—Riluzole—amyotrophic lateral sclerosis	0.000786	0.00698	CcSEcCtD
Topiramate—GRIA4—central nervous system—amyotrophic lateral sclerosis	0.000786	0.00951	CbGeAlD
Topiramate—Breast pain—Riluzole—amyotrophic lateral sclerosis	0.000775	0.00688	CcSEcCtD
Topiramate—Amenorrhoea—Riluzole—amyotrophic lateral sclerosis	0.00077	0.00683	CcSEcCtD
Topiramate—GRIA4—cerebellum—amyotrophic lateral sclerosis	0.000768	0.0093	CbGeAlD
Topiramate—Musculoskeletal stiffness—Riluzole—amyotrophic lateral sclerosis	0.000754	0.00669	CcSEcCtD
Topiramate—GRIK5—nervous system—amyotrophic lateral sclerosis	0.000754	0.00912	CbGeAlD
Topiramate—GRIK3—nervous system—amyotrophic lateral sclerosis	0.000754	0.00912	CbGeAlD
Topiramate—Arthropathy—Riluzole—amyotrophic lateral sclerosis	0.000744	0.0066	CcSEcCtD
Topiramate—Thinking abnormal—Riluzole—amyotrophic lateral sclerosis	0.000739	0.00656	CcSEcCtD
Topiramate—Glossitis—Riluzole—amyotrophic lateral sclerosis	0.000734	0.00651	CcSEcCtD
Topiramate—Nocturia—Riluzole—amyotrophic lateral sclerosis	0.000729	0.00647	CcSEcCtD
Topiramate—GRIK3—central nervous system—amyotrophic lateral sclerosis	0.000726	0.00878	CbGeAlD
Topiramate—GRIK5—central nervous system—amyotrophic lateral sclerosis	0.000726	0.00878	CbGeAlD
Topiramate—GRIK1—nervous system—amyotrophic lateral sclerosis	0.000716	0.00866	CbGeAlD
Topiramate—Dysarthria—Riluzole—amyotrophic lateral sclerosis	0.000715	0.00635	CcSEcCtD
Topiramate—GRIK5—cerebellum—amyotrophic lateral sclerosis	0.000709	0.00858	CbGeAlD
Topiramate—GRIK3—cerebellum—amyotrophic lateral sclerosis	0.000709	0.00858	CbGeAlD
Topiramate—Gait disturbance—Riluzole—amyotrophic lateral sclerosis	0.000693	0.00615	CcSEcCtD
Topiramate—GRIK1—central nervous system—amyotrophic lateral sclerosis	0.000689	0.00834	CbGeAlD
Topiramate—Coordination abnormal—Riluzole—amyotrophic lateral sclerosis	0.000689	0.00611	CcSEcCtD
Topiramate—GRIA1—brainstem—amyotrophic lateral sclerosis	0.000678	0.00821	CbGeAlD
Topiramate—Phosphatase alkaline increased—Riluzole—amyotrophic lateral sclerosis	0.000676	0.006	CcSEcCtD
Topiramate—Pulmonary embolism—Riluzole—amyotrophic lateral sclerosis	0.000676	0.006	CcSEcCtD
Topiramate—GRIK1—cerebellum—amyotrophic lateral sclerosis	0.000674	0.00815	CbGeAlD
Topiramate—GABRB2—hindbrain—amyotrophic lateral sclerosis	0.000669	0.00809	CbGeAlD
Topiramate—GRIA3—nervous system—amyotrophic lateral sclerosis	0.000666	0.00805	CbGeAlD
Topiramate—Melaena—Riluzole—amyotrophic lateral sclerosis	0.000661	0.00586	CcSEcCtD
Topiramate—CA4—nerve—amyotrophic lateral sclerosis	0.000656	0.00794	CbGeAlD
Topiramate—Depressed level of consciousness—Riluzole—amyotrophic lateral sclerosis	0.000653	0.0058	CcSEcCtD
Topiramate—Urinary incontinence—Riluzole—amyotrophic lateral sclerosis	0.000653	0.0058	CcSEcCtD
Topiramate—Candida infection—Riluzole—amyotrophic lateral sclerosis	0.000646	0.00573	CcSEcCtD
Topiramate—Fluid retention—Riluzole—amyotrophic lateral sclerosis	0.000642	0.0057	CcSEcCtD
Topiramate—GRIA3—central nervous system—amyotrophic lateral sclerosis	0.000641	0.00775	CbGeAlD
Topiramate—Photophobia—Riluzole—amyotrophic lateral sclerosis	0.000635	0.00564	CcSEcCtD
Topiramate—GRIA3—cerebellum—amyotrophic lateral sclerosis	0.000626	0.00758	CbGeAlD
Topiramate—GRIA4—brain—amyotrophic lateral sclerosis	0.000624	0.00755	CbGeAlD
Topiramate—Cramps of lower extremities—Riluzole—amyotrophic lateral sclerosis	0.000621	0.00551	CcSEcCtD
Topiramate—Neoplasm—Riluzole—amyotrophic lateral sclerosis	0.000611	0.00543	CcSEcCtD
Topiramate—Hypertonia—Riluzole—amyotrophic lateral sclerosis	0.000593	0.00526	CcSEcCtD
Topiramate—GABRA1—hindbrain—amyotrophic lateral sclerosis	0.000591	0.00714	CbGeAlD
Topiramate—GRIA2—embryo—amyotrophic lateral sclerosis	0.000588	0.00712	CbGeAlD
Topiramate—Mental disability—Riluzole—amyotrophic lateral sclerosis	0.000587	0.00521	CcSEcCtD
Topiramate—Euphoric mood—Riluzole—amyotrophic lateral sclerosis	0.000581	0.00516	CcSEcCtD
Topiramate—GRIK3—brain—amyotrophic lateral sclerosis	0.000576	0.00697	CbGeAlD
Topiramate—GRIK5—brain—amyotrophic lateral sclerosis	0.000576	0.00697	CbGeAlD
Topiramate—Ear pain—Riluzole—amyotrophic lateral sclerosis	0.000575	0.00511	CcSEcCtD
Topiramate—Lymphadenopathy—Riluzole—amyotrophic lateral sclerosis	0.000575	0.00511	CcSEcCtD
Topiramate—Phlebitis—Riluzole—amyotrophic lateral sclerosis	0.00057	0.00506	CcSEcCtD
Topiramate—Diabetes mellitus—Riluzole—amyotrophic lateral sclerosis	0.000564	0.00501	CcSEcCtD
Topiramate—Blood alkaline phosphatase increased—Riluzole—amyotrophic lateral sclerosis	0.000564	0.00501	CcSEcCtD
Topiramate—Vascular purpura—Riluzole—amyotrophic lateral sclerosis	0.000549	0.00487	CcSEcCtD
Topiramate—Deafness—Riluzole—amyotrophic lateral sclerosis	0.000549	0.00487	CcSEcCtD
Topiramate—GRIK1—brain—amyotrophic lateral sclerosis	0.000547	0.00662	CbGeAlD
Topiramate—Eczema—Riluzole—amyotrophic lateral sclerosis	0.000546	0.00485	CcSEcCtD
Topiramate—GRIA2—brainstem—amyotrophic lateral sclerosis	0.000539	0.00652	CbGeAlD
Topiramate—Libido decreased—Riluzole—amyotrophic lateral sclerosis	0.000529	0.0047	CcSEcCtD
Topiramate—Amnesia—Riluzole—amyotrophic lateral sclerosis	0.000523	0.00464	CcSEcCtD
Topiramate—Increased appetite—Riluzole—amyotrophic lateral sclerosis	0.000523	0.00464	CcSEcCtD
Topiramate—Thirst—Riluzole—amyotrophic lateral sclerosis	0.000516	0.00458	CcSEcCtD
Topiramate—Purpura—Riluzole—amyotrophic lateral sclerosis	0.000509	0.00452	CcSEcCtD
Topiramate—GRIA3—brain—amyotrophic lateral sclerosis	0.000509	0.00616	CbGeAlD
Topiramate—Hyponatraemia—Riluzole—amyotrophic lateral sclerosis	0.000493	0.00437	CcSEcCtD
Topiramate—SCN1A—brainstem—amyotrophic lateral sclerosis	0.000492	0.00595	CbGeAlD
Topiramate—CA4—hindbrain—amyotrophic lateral sclerosis	0.000491	0.00595	CbGeAlD
Topiramate—Diplopia—Riluzole—amyotrophic lateral sclerosis	0.000491	0.00436	CcSEcCtD
Topiramate—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.000491	0.00436	CcSEcCtD
Topiramate—Disturbance in sexual arousal—Riluzole—amyotrophic lateral sclerosis	0.000487	0.00432	CcSEcCtD
Topiramate—GRIK2—brainstem—amyotrophic lateral sclerosis	0.000487	0.00589	CbGeAlD
Topiramate—Migraine—Riluzole—amyotrophic lateral sclerosis	0.000483	0.00429	CcSEcCtD
Topiramate—Affect lability—Riluzole—amyotrophic lateral sclerosis	0.000483	0.00429	CcSEcCtD
Topiramate—Psychotic disorder—Riluzole—amyotrophic lateral sclerosis	0.000479	0.00426	CcSEcCtD
Topiramate—Face oedema—Riluzole—amyotrophic lateral sclerosis	0.000474	0.00421	CcSEcCtD
Topiramate—GRIA1—medulla oblongata—amyotrophic lateral sclerosis	0.000473	0.00572	CbGeAlD
Topiramate—Urinary retention—Riluzole—amyotrophic lateral sclerosis	0.000467	0.00414	CcSEcCtD
Topiramate—Mood swings—Riluzole—amyotrophic lateral sclerosis	0.000465	0.00413	CcSEcCtD
Topiramate—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.000462	0.0041	CcSEcCtD
Topiramate—Dehydration—Riluzole—amyotrophic lateral sclerosis	0.000457	0.00405	CcSEcCtD
Topiramate—Liver function test abnormal—Riluzole—amyotrophic lateral sclerosis	0.000453	0.00402	CcSEcCtD
Topiramate—Orthostatic hypotension—Riluzole—amyotrophic lateral sclerosis	0.000448	0.00398	CcSEcCtD
Topiramate—Hypokalaemia—Riluzole—amyotrophic lateral sclerosis	0.000447	0.00397	CcSEcCtD
Topiramate—Breast disorder—Riluzole—amyotrophic lateral sclerosis	0.000444	0.00394	CcSEcCtD
Topiramate—Aspartate aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.000442	0.00392	CcSEcCtD
Topiramate—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.000434	0.00386	CcSEcCtD
Topiramate—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.000433	0.00384	CcSEcCtD
Topiramate—Alanine aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.000433	0.00384	CcSEcCtD
Topiramate—Abdominal distension—Riluzole—amyotrophic lateral sclerosis	0.000427	0.00379	CcSEcCtD
Topiramate—Asthma—Riluzole—amyotrophic lateral sclerosis	0.000424	0.00377	CcSEcCtD
Topiramate—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.000424	0.00377	CcSEcCtD
Topiramate—GRIA1—spinal cord—amyotrophic lateral sclerosis	0.000422	0.0051	CbGeAlD
Topiramate—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.000416	0.00369	CcSEcCtD
Topiramate—Angina pectoris—Riluzole—amyotrophic lateral sclerosis	0.000413	0.00367	CcSEcCtD
Topiramate—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.000408	0.00362	CcSEcCtD
Topiramate—CA2—hindbrain—amyotrophic lateral sclerosis	0.000408	0.00493	CbGeAlD
Topiramate—Abdominal discomfort—Riluzole—amyotrophic lateral sclerosis	0.000407	0.00361	CcSEcCtD
Topiramate—Pancytopenia—Riluzole—amyotrophic lateral sclerosis	0.000403	0.00358	CcSEcCtD
Topiramate—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.000397	0.00352	CcSEcCtD
Topiramate—Neutropenia—Riluzole—amyotrophic lateral sclerosis	0.000397	0.00352	CcSEcCtD
Topiramate—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.000392	0.00348	CcSEcCtD
Topiramate—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.000391	0.00347	CcSEcCtD
Topiramate—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.000387	0.00344	CcSEcCtD
Topiramate—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.000386	0.00343	CcSEcCtD
Topiramate—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.000384	0.00341	CcSEcCtD
Topiramate—GABRB2—brainstem—amyotrophic lateral sclerosis	0.000383	0.00464	CbGeAlD
Topiramate—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.000381	0.00338	CcSEcCtD
Topiramate—Infestation—Riluzole—amyotrophic lateral sclerosis	0.000378	0.00336	CcSEcCtD
Topiramate—Infestation NOS—Riluzole—amyotrophic lateral sclerosis	0.000378	0.00336	CcSEcCtD
Topiramate—Depression—Riluzole—amyotrophic lateral sclerosis	0.000377	0.00335	CcSEcCtD
Topiramate—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.000371	0.00329	CcSEcCtD
Topiramate—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.000369	0.00327	CcSEcCtD
Topiramate—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.000368	0.00326	CcSEcCtD
Topiramate—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.000361	0.0032	CcSEcCtD
Topiramate—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.000357	0.00317	CcSEcCtD
Topiramate—GRIA1—nervous system—amyotrophic lateral sclerosis	0.000355	0.0043	CbGeAlD
Topiramate—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.000355	0.00315	CcSEcCtD
Topiramate—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.000353	0.00313	CcSEcCtD
Topiramate—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.000346	0.00307	CcSEcCtD
Topiramate—CA7—cerebellum—amyotrophic lateral sclerosis	0.000345	0.00418	CbGeAlD
Topiramate—SCN1A—medulla oblongata—amyotrophic lateral sclerosis	0.000343	0.00415	CbGeAlD
Topiramate—GRIA1—central nervous system—amyotrophic lateral sclerosis	0.000342	0.00414	CbGeAlD
Topiramate—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.000341	0.00303	CcSEcCtD
Topiramate—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.00034	0.00302	CcSEcCtD
Topiramate—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.00034	0.00301	CcSEcCtD
Topiramate—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00034	0.00301	CcSEcCtD
Topiramate—GRIK2—medulla oblongata—amyotrophic lateral sclerosis	0.000339	0.00411	CbGeAlD
Topiramate—GABRA1—brainstem—amyotrophic lateral sclerosis	0.000338	0.0041	CbGeAlD
Topiramate—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.000338	0.003	CcSEcCtD
Topiramate—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.000338	0.003	CcSEcCtD
Topiramate—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.000337	0.00299	CcSEcCtD
Topiramate—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.000335	0.00298	CcSEcCtD
Topiramate—GRIA2—spinal cord—amyotrophic lateral sclerosis	0.000335	0.00405	CbGeAlD
Topiramate—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.000335	0.00297	CcSEcCtD
Topiramate—GRIA1—cerebellum—amyotrophic lateral sclerosis	0.000334	0.00405	CbGeAlD
Topiramate—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.000334	0.00296	CcSEcCtD
Topiramate—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.000333	0.00295	CcSEcCtD
Topiramate—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.000321	0.00285	CcSEcCtD
Topiramate—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.000317	0.00282	CcSEcCtD
Topiramate—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.000315	0.0028	CcSEcCtD
Topiramate—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.000308	0.00273	CcSEcCtD
Topiramate—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.000307	0.00272	CcSEcCtD
Topiramate—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.000306	0.00272	CcSEcCtD
Topiramate—SCN1A—spinal cord—amyotrophic lateral sclerosis	0.000306	0.0037	CbGeAlD
Topiramate—Chills—Riluzole—amyotrophic lateral sclerosis	0.000305	0.0027	CcSEcCtD
Topiramate—CA9—cerebellum—amyotrophic lateral sclerosis	0.000303	0.00367	CbGeAlD
Topiramate—GRIK2—spinal cord—amyotrophic lateral sclerosis	0.000303	0.00366	CbGeAlD
Topiramate—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.0003	0.00266	CcSEcCtD
Topiramate—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.000298	0.00264	CcSEcCtD
Topiramate—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.000296	0.00262	CcSEcCtD
Topiramate—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.000291	0.00259	CcSEcCtD
Topiramate—Tension—Riluzole—amyotrophic lateral sclerosis	0.00029	0.00257	CcSEcCtD
Topiramate—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00029	0.00257	CcSEcCtD
Topiramate—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.000287	0.00255	CcSEcCtD
Topiramate—Back pain—Riluzole—amyotrophic lateral sclerosis	0.000286	0.00254	CcSEcCtD
Topiramate—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.000284	0.00252	CcSEcCtD
Topiramate—GRIA2—nervous system—amyotrophic lateral sclerosis	0.000282	0.00342	CbGeAlD
Topiramate—CA4—brainstem—amyotrophic lateral sclerosis	0.000282	0.00341	CbGeAlD
Topiramate—CA7—brain—amyotrophic lateral sclerosis	0.00028	0.00339	CbGeAlD
Topiramate—Tremor—Riluzole—amyotrophic lateral sclerosis	0.000277	0.00246	CcSEcCtD
Topiramate—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.000274	0.00243	CcSEcCtD
Topiramate—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.000273	0.00243	CcSEcCtD
Topiramate—GRIA2—central nervous system—amyotrophic lateral sclerosis	0.000272	0.00329	CbGeAlD
Topiramate—Agitation—Riluzole—amyotrophic lateral sclerosis	0.000272	0.00241	CcSEcCtD
Topiramate—GRIA1—brain—amyotrophic lateral sclerosis	0.000272	0.00329	CbGeAlD
Topiramate—GABRB2—medulla oblongata—amyotrophic lateral sclerosis	0.000267	0.00323	CbGeAlD
Topiramate—GABRG2—medulla oblongata—amyotrophic lateral sclerosis	0.000267	0.00323	CbGeAlD
Topiramate—Malaise—Riluzole—amyotrophic lateral sclerosis	0.000267	0.00237	CcSEcCtD
Topiramate—GRIA2—cerebellum—amyotrophic lateral sclerosis	0.000266	0.00321	CbGeAlD
Topiramate—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.000266	0.00236	CcSEcCtD
Topiramate—Syncope—Riluzole—amyotrophic lateral sclerosis	0.000265	0.00235	CcSEcCtD
Topiramate—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.000265	0.00235	CcSEcCtD
Topiramate—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.000261	0.00232	CcSEcCtD
Topiramate—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00026	0.00231	CcSEcCtD
Topiramate—Cough—Riluzole—amyotrophic lateral sclerosis	0.000258	0.00229	CcSEcCtD
Topiramate—SCN1A—nervous system—amyotrophic lateral sclerosis	0.000258	0.00312	CbGeAlD
Topiramate—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.000256	0.00227	CcSEcCtD
Topiramate—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.000255	0.00227	CcSEcCtD
Topiramate—GRIK2—nervous system—amyotrophic lateral sclerosis	0.000255	0.00309	CbGeAlD
Topiramate—CA2—embryo—amyotrophic lateral sclerosis	0.000255	0.00308	CbGeAlD
Topiramate—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.000252	0.00223	CcSEcCtD
Topiramate—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.000252	0.00223	CcSEcCtD
Topiramate—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.000252	0.00223	CcSEcCtD
Topiramate—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.000251	0.00223	CcSEcCtD
Topiramate—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00025	0.00222	CcSEcCtD
Topiramate—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.000249	0.00221	CcSEcCtD
Topiramate—SCN1A—central nervous system—amyotrophic lateral sclerosis	0.000248	0.003	CbGeAlD
Topiramate—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.000246	0.00218	CcSEcCtD
Topiramate—GRIK2—central nervous system—amyotrophic lateral sclerosis	0.000246	0.00297	CbGeAlD
Topiramate—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.000243	0.00216	CcSEcCtD
Topiramate—SCN1A—cerebellum—amyotrophic lateral sclerosis	0.000242	0.00293	CbGeAlD
Topiramate—Oedema—Riluzole—amyotrophic lateral sclerosis	0.000241	0.00214	CcSEcCtD
Topiramate—GRIK2—cerebellum—amyotrophic lateral sclerosis	0.00024	0.0029	CbGeAlD
Topiramate—Infection—Riluzole—amyotrophic lateral sclerosis	0.00024	0.00213	CcSEcCtD
Topiramate—CA12—nervous system—amyotrophic lateral sclerosis	0.000238	0.00288	CbGeAlD
Topiramate—GABRB2—spinal cord—amyotrophic lateral sclerosis	0.000238	0.00288	CbGeAlD
Topiramate—GABRG2—spinal cord—amyotrophic lateral sclerosis	0.000238	0.00288	CbGeAlD
Topiramate—Shock—Riluzole—amyotrophic lateral sclerosis	0.000237	0.00211	CcSEcCtD
Topiramate—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.000237	0.0021	CcSEcCtD
Topiramate—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.000236	0.0021	CcSEcCtD
Topiramate—GABRA1—medulla oblongata—amyotrophic lateral sclerosis	0.000236	0.00286	CbGeAlD
Topiramate—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.000235	0.00209	CcSEcCtD
Topiramate—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.000234	0.00208	CcSEcCtD
Topiramate—CA2—brainstem—amyotrophic lateral sclerosis	0.000234	0.00283	CbGeAlD
Topiramate—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.000233	0.00207	CcSEcCtD
Topiramate—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00023	0.00204	CcSEcCtD
Topiramate—CA12—central nervous system—amyotrophic lateral sclerosis	0.000229	0.00278	CbGeAlD
Topiramate—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.000225	0.002	CcSEcCtD
Topiramate—CA1—spinal cord—amyotrophic lateral sclerosis	0.000224	0.00271	CbGeAlD
Topiramate—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00022	0.00195	CcSEcCtD
Topiramate—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.000218	0.00194	CcSEcCtD
Topiramate—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.000217	0.00192	CcSEcCtD
Topiramate—GRIA2—brain—amyotrophic lateral sclerosis	0.000216	0.00261	CbGeAlD
Topiramate—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.000215	0.00191	CcSEcCtD
Topiramate—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.000215	0.0019	CcSEcCtD
Topiramate—CA5B—nervous system—amyotrophic lateral sclerosis	0.000214	0.00259	CbGeAlD
Topiramate—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.000212	0.00189	CcSEcCtD
Topiramate—GABRA1—spinal cord—amyotrophic lateral sclerosis	0.00021	0.00255	CbGeAlD
Topiramate—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00021	0.00186	CcSEcCtD
Topiramate—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.000208	0.00185	CcSEcCtD
Topiramate—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.000208	0.00185	CcSEcCtD
Topiramate—SCN5A—nervous system—amyotrophic lateral sclerosis	0.000207	0.00251	CbGeAlD
Topiramate—Pain—Riluzole—amyotrophic lateral sclerosis	0.000206	0.00183	CcSEcCtD
Topiramate—Constipation—Riluzole—amyotrophic lateral sclerosis	0.000206	0.00183	CcSEcCtD
Topiramate—CA5B—central nervous system—amyotrophic lateral sclerosis	0.000206	0.00249	CbGeAlD
Topiramate—GABRB2—nervous system—amyotrophic lateral sclerosis	0.000201	0.00243	CbGeAlD
Topiramate—GABRG2—nervous system—amyotrophic lateral sclerosis	0.000201	0.00243	CbGeAlD
Topiramate—SCN5A—central nervous system—amyotrophic lateral sclerosis	0.000199	0.00241	CbGeAlD
Topiramate—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.000199	0.00176	CcSEcCtD
Topiramate—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.000197	0.00175	CcSEcCtD
Topiramate—SCN1A—brain—amyotrophic lateral sclerosis	0.000197	0.00238	CbGeAlD
Topiramate—CA4—medulla oblongata—amyotrophic lateral sclerosis	0.000196	0.00238	CbGeAlD
Topiramate—GRIK2—brain—amyotrophic lateral sclerosis	0.000195	0.00236	CbGeAlD
Topiramate—GABRB2—central nervous system—amyotrophic lateral sclerosis	0.000193	0.00234	CbGeAlD
Topiramate—GABRG2—central nervous system—amyotrophic lateral sclerosis	0.000193	0.00234	CbGeAlD
Topiramate—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.000192	0.0017	CcSEcCtD
Topiramate—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.000191	0.00169	CcSEcCtD
Topiramate—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.000191	0.00169	CcSEcCtD
Topiramate—GABRB2—cerebellum—amyotrophic lateral sclerosis	0.000189	0.00229	CbGeAlD
Topiramate—GABRG2—cerebellum—amyotrophic lateral sclerosis	0.000189	0.00229	CbGeAlD
Topiramate—CA1—nervous system—amyotrophic lateral sclerosis	0.000189	0.00228	CbGeAlD
Topiramate—CA12—brain—amyotrophic lateral sclerosis	0.000182	0.0022	CbGeAlD
Topiramate—CA1—central nervous system—amyotrophic lateral sclerosis	0.000182	0.0022	CbGeAlD
Topiramate—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.000178	0.00158	CcSEcCtD
Topiramate—GABRA1—nervous system—amyotrophic lateral sclerosis	0.000177	0.00215	CbGeAlD
Topiramate—CA4—spinal cord—amyotrophic lateral sclerosis	0.000175	0.00212	CbGeAlD
Topiramate—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.000173	0.00154	CcSEcCtD
Topiramate—GABRA1—central nervous system—amyotrophic lateral sclerosis	0.000171	0.00207	CbGeAlD
Topiramate—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.000171	0.00152	CcSEcCtD
Topiramate—GABRA1—cerebellum—amyotrophic lateral sclerosis	0.000167	0.00202	CbGeAlD
Topiramate—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.000165	0.00147	CcSEcCtD
Topiramate—CA5B—brain—amyotrophic lateral sclerosis	0.000163	0.00198	CbGeAlD
Topiramate—CA2—medulla oblongata—amyotrophic lateral sclerosis	0.000163	0.00197	CbGeAlD
Topiramate—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00016	0.00142	CcSEcCtD
Topiramate—SCN5A—brain—amyotrophic lateral sclerosis	0.000158	0.00192	CbGeAlD
Topiramate—GABRB2—brain—amyotrophic lateral sclerosis	0.000154	0.00186	CbGeAlD
Topiramate—GABRG2—brain—amyotrophic lateral sclerosis	0.000154	0.00186	CbGeAlD
Topiramate—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.000153	0.00136	CcSEcCtD
Topiramate—Rash—Riluzole—amyotrophic lateral sclerosis	0.000152	0.00135	CcSEcCtD
Topiramate—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000152	0.00135	CcSEcCtD
Topiramate—Headache—Riluzole—amyotrophic lateral sclerosis	0.000151	0.00134	CcSEcCtD
Topiramate—CA4—nervous system—amyotrophic lateral sclerosis	0.000148	0.00179	CbGeAlD
Topiramate—CA2—spinal cord—amyotrophic lateral sclerosis	0.000145	0.00176	CbGeAlD
Topiramate—CA1—brain—amyotrophic lateral sclerosis	0.000144	0.00175	CbGeAlD
Topiramate—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000143	0.00127	CcSEcCtD
Topiramate—CA4—central nervous system—amyotrophic lateral sclerosis	0.000142	0.00172	CbGeAlD
Topiramate—CA4—cerebellum—amyotrophic lateral sclerosis	0.000139	0.00168	CbGeAlD
Topiramate—GABRA1—brain—amyotrophic lateral sclerosis	0.000136	0.00164	CbGeAlD
Topiramate—CA2—nervous system—amyotrophic lateral sclerosis	0.000122	0.00148	CbGeAlD
Topiramate—CA2—central nervous system—amyotrophic lateral sclerosis	0.000118	0.00143	CbGeAlD
Topiramate—CA2—cerebellum—amyotrophic lateral sclerosis	0.000115	0.00139	CbGeAlD
Topiramate—CA4—brain—amyotrophic lateral sclerosis	0.000113	0.00136	CbGeAlD
Topiramate—CA2—brain—amyotrophic lateral sclerosis	9.35e-05	0.00113	CbGeAlD
Topiramate—CYP3A4—nervous system—amyotrophic lateral sclerosis	7.9e-05	0.000955	CbGeAlD
Topiramate—GRIA2—BDNF signaling pathway—SQSTM1—amyotrophic lateral sclerosis	7.77e-05	0.000699	CbGpPWpGaD
Topiramate—GRIK2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	7.77e-05	0.000698	CbGpPWpGaD
Topiramate—GRIA2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	7.75e-05	0.000697	CbGpPWpGaD
Topiramate—SCN5A—Cardiac Progenitor Differentiation—IGF1—amyotrophic lateral sclerosis	7.7e-05	0.000692	CbGpPWpGaD
Topiramate—GABRB2—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	7.68e-05	0.000691	CbGpPWpGaD
Topiramate—CYP3A4—central nervous system—amyotrophic lateral sclerosis	7.6e-05	0.00092	CbGeAlD
Topiramate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	7.47e-05	0.000672	CbGpPWpGaD
Topiramate—CA7—Metabolism—VAPB—amyotrophic lateral sclerosis	7.46e-05	0.000671	CbGpPWpGaD
Topiramate—CA5B—Metabolism—TPK1—amyotrophic lateral sclerosis	7.46e-05	0.000671	CbGpPWpGaD
Topiramate—CA7—Metabolism—TPK1—amyotrophic lateral sclerosis	7.46e-05	0.000671	CbGpPWpGaD
Topiramate—CA5B—Metabolism—VAPB—amyotrophic lateral sclerosis	7.46e-05	0.000671	CbGpPWpGaD
Topiramate—CA6—Metabolism—VAPA—amyotrophic lateral sclerosis	7.31e-05	0.000657	CbGpPWpGaD
Topiramate—CA5A—Metabolism—VAPA—amyotrophic lateral sclerosis	7.31e-05	0.000657	CbGpPWpGaD
Topiramate—GABRG2—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	7.27e-05	0.000654	CbGpPWpGaD
Topiramate—GRIA2—Neuronal System—NEFL—amyotrophic lateral sclerosis	7.17e-05	0.000644	CbGpPWpGaD
Topiramate—GABRG2—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	7.03e-05	0.000632	CbGpPWpGaD
Topiramate—GABRB2—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	7.03e-05	0.000632	CbGpPWpGaD
Topiramate—GRIA3—BDNF signaling pathway—CASP3—amyotrophic lateral sclerosis	6.98e-05	0.000627	CbGpPWpGaD
Topiramate—CA12—Metabolism—TPK1—amyotrophic lateral sclerosis	6.91e-05	0.000621	CbGpPWpGaD
Topiramate—CA12—Metabolism—VAPB—amyotrophic lateral sclerosis	6.91e-05	0.000621	CbGpPWpGaD
Topiramate—GABRA1—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	6.89e-05	0.000619	CbGpPWpGaD
Topiramate—CA7—Metabolism—VAPA—amyotrophic lateral sclerosis	6.82e-05	0.000613	CbGpPWpGaD
Topiramate—CA5B—Metabolism—VAPA—amyotrophic lateral sclerosis	6.82e-05	0.000613	CbGpPWpGaD
Topiramate—CA5A—Metabolism—SACM1L—amyotrophic lateral sclerosis	6.79e-05	0.000611	CbGpPWpGaD
Topiramate—CA6—Metabolism—SACM1L—amyotrophic lateral sclerosis	6.79e-05	0.000611	CbGpPWpGaD
Topiramate—GRIA2—Neuronal System—CHAT—amyotrophic lateral sclerosis	6.66e-05	0.000599	CbGpPWpGaD
Topiramate—GRIA2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	6.66e-05	0.000599	CbGpPWpGaD
Topiramate—GABRB2—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	6.6e-05	0.000594	CbGpPWpGaD
Topiramate—GABRB2—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	6.53e-05	0.000587	CbGpPWpGaD
Topiramate—GABRB2—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	6.53e-05	0.000587	CbGpPWpGaD
Topiramate—GABRG2—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	6.43e-05	0.000578	CbGpPWpGaD
Topiramate—CA5A—Metabolism—FIG4—amyotrophic lateral sclerosis	6.39e-05	0.000574	CbGpPWpGaD
Topiramate—CA6—Metabolism—FIG4—amyotrophic lateral sclerosis	6.39e-05	0.000574	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—AQP4—amyotrophic lateral sclerosis	6.37e-05	0.000573	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—CHAT—amyotrophic lateral sclerosis	6.37e-05	0.000573	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—SLC1A3—amyotrophic lateral sclerosis	6.37e-05	0.000573	CbGpPWpGaD
Topiramate—GABRA1—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	6.36e-05	0.000572	CbGpPWpGaD
Topiramate—CA7—Metabolism—SACM1L—amyotrophic lateral sclerosis	6.34e-05	0.00057	CbGpPWpGaD
Topiramate—CA5B—Metabolism—SACM1L—amyotrophic lateral sclerosis	6.34e-05	0.00057	CbGpPWpGaD
Topiramate—CA12—Metabolism—VAPA—amyotrophic lateral sclerosis	6.32e-05	0.000568	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—PFN1—amyotrophic lateral sclerosis	6.23e-05	0.00056	CbGpPWpGaD
Topiramate—GABRA1—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	6.14e-05	0.000552	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—PFN1—amyotrophic lateral sclerosis	6.14e-05	0.000552	CbGpPWpGaD
Topiramate—GABRB2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	6.09e-05	0.000548	CbGpPWpGaD
Topiramate—CA1—C-MYB transcription factor network—PTGS2—amyotrophic lateral sclerosis	6.08e-05	0.000546	CbGpPWpGaD
Topiramate—GABRG2—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	6.04e-05	0.000543	CbGpPWpGaD
Topiramate—GABRG2—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	5.97e-05	0.000537	CbGpPWpGaD
Topiramate—GABRG2—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	5.97e-05	0.000537	CbGpPWpGaD
Topiramate—CA5B—Metabolism—FIG4—amyotrophic lateral sclerosis	5.96e-05	0.000536	CbGpPWpGaD
Topiramate—CA7—Metabolism—FIG4—amyotrophic lateral sclerosis	5.96e-05	0.000536	CbGpPWpGaD
Topiramate—GRIA2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	5.94e-05	0.000534	CbGpPWpGaD
Topiramate—GABRB2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	5.89e-05	0.000529	CbGpPWpGaD
Topiramate—CA12—Metabolism—SACM1L—amyotrophic lateral sclerosis	5.88e-05	0.000528	CbGpPWpGaD
Topiramate—GRIA2—BDNF signaling pathway—BDNF—amyotrophic lateral sclerosis	5.85e-05	0.000526	CbGpPWpGaD
Topiramate—GABRB2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	5.82e-05	0.000523	CbGpPWpGaD
Topiramate—CA5A—Metabolism—DAO—amyotrophic lateral sclerosis	5.78e-05	0.000519	CbGpPWpGaD
Topiramate—CA6—Metabolism—DAO—amyotrophic lateral sclerosis	5.78e-05	0.000519	CbGpPWpGaD
Topiramate—GABRA1—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	5.62e-05	0.000505	CbGpPWpGaD
Topiramate—GABRG2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	5.57e-05	0.000501	CbGpPWpGaD
Topiramate—CA12—Metabolism—FIG4—amyotrophic lateral sclerosis	5.53e-05	0.000497	CbGpPWpGaD
Topiramate—CA4—Metabolism—VAPB—amyotrophic lateral sclerosis	5.51e-05	0.000495	CbGpPWpGaD
Topiramate—CA4—Metabolism—TPK1—amyotrophic lateral sclerosis	5.51e-05	0.000495	CbGpPWpGaD
Topiramate—CA5B—Metabolism—DAO—amyotrophic lateral sclerosis	5.39e-05	0.000485	CbGpPWpGaD
Topiramate—CA7—Metabolism—DAO—amyotrophic lateral sclerosis	5.39e-05	0.000485	CbGpPWpGaD
Topiramate—GABRG2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	5.38e-05	0.000484	CbGpPWpGaD
Topiramate—GABRB2—Neuronal System—NEFL—amyotrophic lateral sclerosis	5.38e-05	0.000484	CbGpPWpGaD
Topiramate—GABRG2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	5.32e-05	0.000479	CbGpPWpGaD
Topiramate—CA2—Metabolism—VAPB—amyotrophic lateral sclerosis	5.28e-05	0.000475	CbGpPWpGaD
Topiramate—CA2—Metabolism—TPK1—amyotrophic lateral sclerosis	5.28e-05	0.000475	CbGpPWpGaD
Topiramate—GABRA1—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	5.28e-05	0.000475	CbGpPWpGaD
Topiramate—GABRA1—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	5.22e-05	0.000469	CbGpPWpGaD
Topiramate—GABRA1—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	5.22e-05	0.000469	CbGpPWpGaD
Topiramate—CYP2C19—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	5.11e-05	0.000459	CbGpPWpGaD
Topiramate—CA9—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	5.1e-05	0.000459	CbGpPWpGaD
Topiramate—CA1—Metabolism—VAPB—amyotrophic lateral sclerosis	5.07e-05	0.000455	CbGpPWpGaD
Topiramate—CA1—Metabolism—TPK1—amyotrophic lateral sclerosis	5.07e-05	0.000455	CbGpPWpGaD
Topiramate—CA4—Metabolism—VAPA—amyotrophic lateral sclerosis	5.04e-05	0.000453	CbGpPWpGaD
Topiramate—GABRB2—Neuronal System—CHAT—amyotrophic lateral sclerosis	5e-05	0.00045	CbGpPWpGaD
Topiramate—GABRB2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	5e-05	0.00045	CbGpPWpGaD
Topiramate—SCN5A—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	5e-05	0.00045	CbGpPWpGaD
Topiramate—CA12—Metabolism—DAO—amyotrophic lateral sclerosis	5e-05	0.000449	CbGpPWpGaD
Topiramate—GABRG2—Neuronal System—NEFL—amyotrophic lateral sclerosis	4.92e-05	0.000443	CbGpPWpGaD
Topiramate—GABRB2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	4.91e-05	0.000441	CbGpPWpGaD
Topiramate—GABRA1—Neuronal System—GRIA2—amyotrophic lateral sclerosis	4.87e-05	0.000438	CbGpPWpGaD
Topiramate—CA2—Metabolism—VAPA—amyotrophic lateral sclerosis	4.83e-05	0.000434	CbGpPWpGaD
Topiramate—GABRA1—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	4.71e-05	0.000423	CbGpPWpGaD
Topiramate—CA4—Metabolism—SACM1L—amyotrophic lateral sclerosis	4.69e-05	0.000421	CbGpPWpGaD
Topiramate—GABRA1—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	4.65e-05	0.000418	CbGpPWpGaD
Topiramate—CA1—Metabolism—VAPA—amyotrophic lateral sclerosis	4.63e-05	0.000417	CbGpPWpGaD
Topiramate—GABRG2—Neuronal System—CHAT—amyotrophic lateral sclerosis	4.58e-05	0.000411	CbGpPWpGaD
Topiramate—GABRG2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	4.58e-05	0.000411	CbGpPWpGaD
Topiramate—CA2—Metabolism—SACM1L—amyotrophic lateral sclerosis	4.49e-05	0.000404	CbGpPWpGaD
Topiramate—GABRG2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	4.49e-05	0.000404	CbGpPWpGaD
Topiramate—GABRB2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	4.46e-05	0.000401	CbGpPWpGaD
Topiramate—CA9—Metabolism—TPK1—amyotrophic lateral sclerosis	4.45e-05	0.0004	CbGpPWpGaD
Topiramate—CA9—Metabolism—VAPB—amyotrophic lateral sclerosis	4.45e-05	0.0004	CbGpPWpGaD
Topiramate—CA4—Metabolism—FIG4—amyotrophic lateral sclerosis	4.41e-05	0.000396	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—PFN1—amyotrophic lateral sclerosis	4.38e-05	0.000394	CbGpPWpGaD
Topiramate—CA5A—Metabolism—PLB1—amyotrophic lateral sclerosis	4.38e-05	0.000394	CbGpPWpGaD
Topiramate—CA6—Metabolism—PLB1—amyotrophic lateral sclerosis	4.38e-05	0.000394	CbGpPWpGaD
Topiramate—CA1—Metabolism—SACM1L—amyotrophic lateral sclerosis	4.31e-05	0.000387	CbGpPWpGaD
Topiramate—GABRA1—Neuronal System—NEFL—amyotrophic lateral sclerosis	4.3e-05	0.000387	CbGpPWpGaD
Topiramate—CA9—Cellular responses to stress—SOD1—amyotrophic lateral sclerosis	4.23e-05	0.00038	CbGpPWpGaD
Topiramate—CA2—Metabolism—FIG4—amyotrophic lateral sclerosis	4.22e-05	0.00038	CbGpPWpGaD
Topiramate—GRIA1—BDNF signaling pathway—CASP3—amyotrophic lateral sclerosis	4.18e-05	0.000376	CbGpPWpGaD
Topiramate—CA9—Cellular responses to stress—GSTP1—amyotrophic lateral sclerosis	4.13e-05	0.000371	CbGpPWpGaD
Topiramate—CA5B—Metabolism—PLB1—amyotrophic lateral sclerosis	4.09e-05	0.000367	CbGpPWpGaD
Topiramate—CA7—Metabolism—PLB1—amyotrophic lateral sclerosis	4.09e-05	0.000367	CbGpPWpGaD
Topiramate—GABRG2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	4.08e-05	0.000367	CbGpPWpGaD
Topiramate—CA9—Metabolism—VAPA—amyotrophic lateral sclerosis	4.07e-05	0.000366	CbGpPWpGaD
Topiramate—CA1—Metabolism—FIG4—amyotrophic lateral sclerosis	4.05e-05	0.000364	CbGpPWpGaD
Topiramate—CA5A—Metabolism—GSR—amyotrophic lateral sclerosis	4.04e-05	0.000363	CbGpPWpGaD
Topiramate—CA6—Metabolism—GSR—amyotrophic lateral sclerosis	4.04e-05	0.000363	CbGpPWpGaD
Topiramate—CYP2C19—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.02e-05	0.000361	CbGpPWpGaD
Topiramate—GABRA1—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	4e-05	0.00036	CbGpPWpGaD
Topiramate—GABRA1—Neuronal System—CHAT—amyotrophic lateral sclerosis	4e-05	0.00036	CbGpPWpGaD
Topiramate—CA4—Metabolism—DAO—amyotrophic lateral sclerosis	3.98e-05	0.000358	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	3.93e-05	0.000353	CbGpPWpGaD
Topiramate—CA2—Metabolism—DAO—amyotrophic lateral sclerosis	3.82e-05	0.000343	CbGpPWpGaD
Topiramate—CA12—Metabolism—PLB1—amyotrophic lateral sclerosis	3.79e-05	0.00034	CbGpPWpGaD
Topiramate—CA9—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.79e-05	0.00034	CbGpPWpGaD
Topiramate—CA7—Metabolism—GSR—amyotrophic lateral sclerosis	3.77e-05	0.000339	CbGpPWpGaD
Topiramate—CA5B—Metabolism—GSR—amyotrophic lateral sclerosis	3.77e-05	0.000339	CbGpPWpGaD
Topiramate—CA1—Metabolism—DAO—amyotrophic lateral sclerosis	3.66e-05	0.000329	CbGpPWpGaD
Topiramate—CYP2C19—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	3.64e-05	0.000327	CbGpPWpGaD
Topiramate—GABRA1—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	3.57e-05	0.000321	CbGpPWpGaD
Topiramate—CA9—Metabolism—FIG4—amyotrophic lateral sclerosis	3.56e-05	0.00032	CbGpPWpGaD
Topiramate—CA12—Metabolism—GSR—amyotrophic lateral sclerosis	3.49e-05	0.000314	CbGpPWpGaD
Topiramate—CA6—Metabolism—CHAT—amyotrophic lateral sclerosis	3.32e-05	0.000298	CbGpPWpGaD
Topiramate—CA5A—Metabolism—CHAT—amyotrophic lateral sclerosis	3.32e-05	0.000298	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	3.3e-05	0.000296	CbGpPWpGaD
Topiramate—CA9—Metabolism—DAO—amyotrophic lateral sclerosis	3.22e-05	0.000289	CbGpPWpGaD
Topiramate—GABRB2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	3.16e-05	0.000284	CbGpPWpGaD
Topiramate—CA7—Metabolism—CHAT—amyotrophic lateral sclerosis	3.1e-05	0.000278	CbGpPWpGaD
Topiramate—CA5B—Metabolism—CHAT—amyotrophic lateral sclerosis	3.1e-05	0.000278	CbGpPWpGaD
Topiramate—CA4—Metabolism—PLB1—amyotrophic lateral sclerosis	3.02e-05	0.000271	CbGpPWpGaD
Topiramate—GRIA2—BDNF signaling pathway—CASP3—amyotrophic lateral sclerosis	2.92e-05	0.000263	CbGpPWpGaD
Topiramate—CA2—Metabolism—PLB1—amyotrophic lateral sclerosis	2.9e-05	0.00026	CbGpPWpGaD
Topiramate—GABRG2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	2.89e-05	0.00026	CbGpPWpGaD
Topiramate—CA12—Metabolism—CHAT—amyotrophic lateral sclerosis	2.87e-05	0.000258	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	2.8e-05	0.000252	CbGpPWpGaD
Topiramate—CA4—Metabolism—GSR—amyotrophic lateral sclerosis	2.79e-05	0.000251	CbGpPWpGaD
Topiramate—CA1—Metabolism—PLB1—amyotrophic lateral sclerosis	2.78e-05	0.00025	CbGpPWpGaD
Topiramate—GABRB2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	2.69e-05	0.000242	CbGpPWpGaD
Topiramate—GABRB2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	2.69e-05	0.000242	CbGpPWpGaD
Topiramate—CA2—Metabolism—GSR—amyotrophic lateral sclerosis	2.67e-05	0.00024	CbGpPWpGaD
Topiramate—CA1—Metabolism—GSR—amyotrophic lateral sclerosis	2.56e-05	0.00023	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	2.56e-05	0.00023	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	2.53e-05	0.000227	CbGpPWpGaD
Topiramate—SCN5A—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	2.5e-05	0.000225	CbGpPWpGaD
Topiramate—GABRG2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	2.46e-05	0.000221	CbGpPWpGaD
Topiramate—GABRG2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	2.46e-05	0.000221	CbGpPWpGaD
Topiramate—CA9—Metabolism—PLB1—amyotrophic lateral sclerosis	2.44e-05	0.000219	CbGpPWpGaD
Topiramate—GABRB2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	2.4e-05	0.000216	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	2.38e-05	0.000214	CbGpPWpGaD
Topiramate—CA4—Metabolism—CHAT—amyotrophic lateral sclerosis	2.29e-05	0.000206	CbGpPWpGaD
Topiramate—CYP2C19—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	2.26e-05	0.000204	CbGpPWpGaD
Topiramate—CA9—Metabolism—GSR—amyotrophic lateral sclerosis	2.25e-05	0.000202	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	2.24e-05	0.000201	CbGpPWpGaD
Topiramate—CA2—Metabolism—CHAT—amyotrophic lateral sclerosis	2.19e-05	0.000197	CbGpPWpGaD
Topiramate—GABRG2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	2.19e-05	0.000197	CbGpPWpGaD
Topiramate—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	2.19e-05	0.000197	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	2.15e-05	0.000193	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	2.15e-05	0.000193	CbGpPWpGaD
Topiramate—SCN5A—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	2.12e-05	0.000191	CbGpPWpGaD
Topiramate—CA1—Metabolism—CHAT—amyotrophic lateral sclerosis	2.1e-05	0.000189	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	1.92e-05	0.000172	CbGpPWpGaD
Topiramate—SCN1A—Axon guidance—MMP9—amyotrophic lateral sclerosis	1.87e-05	0.000168	CbGpPWpGaD
Topiramate—CA9—Metabolism—CHAT—amyotrophic lateral sclerosis	1.85e-05	0.000166	CbGpPWpGaD
Topiramate—CA5A—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.78e-05	0.00016	CbGpPWpGaD
Topiramate—CA6—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.78e-05	0.00016	CbGpPWpGaD
Topiramate—CA9—Cellular responses to stress—VEGFA—amyotrophic lateral sclerosis	1.68e-05	0.000151	CbGpPWpGaD
Topiramate—SCN1A—Axon guidance—VEGFA—amyotrophic lateral sclerosis	1.68e-05	0.000151	CbGpPWpGaD
Topiramate—CA5B—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.66e-05	0.00015	CbGpPWpGaD
Topiramate—CA7—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.66e-05	0.00015	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	1.65e-05	0.000148	CbGpPWpGaD
Topiramate—CA6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.64e-05	0.000147	CbGpPWpGaD
Topiramate—CA5A—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.64e-05	0.000147	CbGpPWpGaD
Topiramate—CYP2C19—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	1.63e-05	0.000146	CbGpPWpGaD
Topiramate—CYP2C19—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	1.6e-05	0.000144	CbGpPWpGaD
Topiramate—CA12—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.54e-05	0.000139	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	1.53e-05	0.000138	CbGpPWpGaD
Topiramate—CA5B—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.53e-05	0.000138	CbGpPWpGaD
Topiramate—CA7—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.53e-05	0.000138	CbGpPWpGaD
Topiramate—CA12—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.42e-05	0.000127	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	1.4e-05	0.000126	CbGpPWpGaD
Topiramate—CA5A—Metabolism—APOE—amyotrophic lateral sclerosis	1.35e-05	0.000121	CbGpPWpGaD
Topiramate—CA6—Metabolism—APOE—amyotrophic lateral sclerosis	1.35e-05	0.000121	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—MMP9—amyotrophic lateral sclerosis	1.34e-05	0.00012	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—MMP9—amyotrophic lateral sclerosis	1.32e-05	0.000118	CbGpPWpGaD
Topiramate—CA9—Cellular responses to stress—TP53—amyotrophic lateral sclerosis	1.27e-05	0.000114	CbGpPWpGaD
Topiramate—CA5B—Metabolism—APOE—amyotrophic lateral sclerosis	1.26e-05	0.000113	CbGpPWpGaD
Topiramate—CA7—Metabolism—APOE—amyotrophic lateral sclerosis	1.26e-05	0.000113	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—VAPB—amyotrophic lateral sclerosis	1.25e-05	0.000112	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—TPK1—amyotrophic lateral sclerosis	1.25e-05	0.000112	CbGpPWpGaD
Topiramate—CA4—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.23e-05	0.000111	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	1.2e-05	0.000108	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—VEGFA—amyotrophic lateral sclerosis	1.18e-05	0.000106	CbGpPWpGaD
Topiramate—CA2—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.18e-05	0.000106	CbGpPWpGaD
Topiramate—CA12—Metabolism—APOE—amyotrophic lateral sclerosis	1.17e-05	0.000105	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	1.16e-05	0.000105	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—VAPA—amyotrophic lateral sclerosis	1.14e-05	0.000103	CbGpPWpGaD
Topiramate—CA1—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.13e-05	0.000102	CbGpPWpGaD
Topiramate—CA4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.13e-05	0.000102	CbGpPWpGaD
Topiramate—CA2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.08e-05	9.74e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.06e-05	9.53e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.04e-05	9.34e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—FIG4—amyotrophic lateral sclerosis	9.97e-06	8.96e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—GSTP1—amyotrophic lateral sclerosis	9.94e-06	8.94e-05	CbGpPWpGaD
Topiramate—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	9.78e-06	8.8e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	9.65e-06	8.68e-05	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—MMP9—amyotrophic lateral sclerosis	9.39e-06	8.44e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—APOE—amyotrophic lateral sclerosis	9.3e-06	8.36e-05	CbGpPWpGaD
Topiramate—CA5A—Metabolism—PTGS2—amyotrophic lateral sclerosis	9.24e-06	8.31e-05	CbGpPWpGaD
Topiramate—CA6—Metabolism—PTGS2—amyotrophic lateral sclerosis	9.24e-06	8.31e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.13e-06	8.21e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—DAO—amyotrophic lateral sclerosis	9.01e-06	8.1e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—APOE—amyotrophic lateral sclerosis	8.92e-06	8.02e-05	CbGpPWpGaD
Topiramate—CA5B—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.63e-06	7.75e-05	CbGpPWpGaD
Topiramate—CA7—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.63e-06	7.75e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—APOE—amyotrophic lateral sclerosis	8.55e-06	7.68e-05	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	8.43e-06	7.58e-05	CbGpPWpGaD
Topiramate—CA12—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.99e-06	7.18e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—APOE—amyotrophic lateral sclerosis	7.51e-06	6.76e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	7.5e-06	6.74e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	7.5e-06	6.74e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	6.86e-06	6.16e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PLB1—amyotrophic lateral sclerosis	6.83e-06	6.14e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	6.37e-06	5.73e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.37e-06	5.73e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GSR—amyotrophic lateral sclerosis	6.3e-06	5.67e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.11e-06	5.49e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	5.99e-06	5.39e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.86e-06	5.27e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	5.74e-06	5.16e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	5.42e-06	4.87e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CHAT—amyotrophic lateral sclerosis	5.18e-06	4.65e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.15e-06	4.63e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	4.72e-06	4.25e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	4.11e-06	3.69e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	3.79e-06	3.41e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	3.24e-06	2.91e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	3.11e-06	2.8e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.78e-06	2.5e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.56e-06	2.3e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—APOE—amyotrophic lateral sclerosis	2.1e-06	1.89e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.67e-06	1.5e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.54e-06	1.38e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.44e-06	1.3e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	1.27e-06	1.14e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.67e-07	7.79e-06	CbGpPWpGaD
